A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2004
12/08/2004	EP1482789A2 Palatable oral suspension and method
12/08/2004	EP1444247A4 Novel tibolone formulations
12/08/2004	EP1436283A4 Method for preparing pyrimidinone compound and pharmaceutically acceptable salts thereof
12/08/2004	EP1432312A4 Use of non-toxic crosslinking reagents to improve fatigue resistance and reduce mechanical degradation of intervertebral disc and other collagenous tissues
12/08/2004	EP1412341B1 Process for the preparation of racemic citalopram and/or s- or r-citalopram by separation of a mixture of r- and s-citalopram
12/08/2004	EP1381363B1 Imidazo [1,2-a]-pyridine derivatives as mglur5 antagonists
12/08/2004	EP1363898A4 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
12/08/2004	EP1341754B1 Substituted anthranilic acids
12/08/2004	EP1339403B1 Repinotan kit
12/08/2004	EP1305286B1 Cyclopentanoindoles, compositions containing such compounds and methods of treatment
12/08/2004	EP1252155B1 Ethanol solvate of (-)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8- [4r-(3s-hydroxy-1-methyl)piperidinyl]-4h-1-benzopyran-4-one
12/08/2004	EP1251120B1 Esters derived from (rr,ss)-2-hydroxybenzoate of 3-(2-dimethylaminomethyl-1-hydroxycyclohexyl)phenyl
12/08/2004	EP1240152B1 Ox(adi)azolyl-hydroxamic acids useful as procollagen c-proteinase inhibitors
12/08/2004	EP1233787B1 Product inhibiting transduction of g heterotrimeric protein signals combined with another anti-cancer agent for therapeutic use in cancer treatment
12/08/2004	EP1224164B1 Hydroxamic acid derivative as inhibitor of the formation of soluble human cd23
12/08/2004	EP1221947B1 Soft gel capsule resistant to gastric juices
12/08/2004	EP1220856B1 Pyrazolo[4,3-d]pyrimidine derivatives
12/08/2004	EP1220669A4 Therapeutic intervention to mimic the effect of caloric restriction
12/08/2004	EP1218370B1 Quinolyl propyl piperidine derivatives and their use as antibacterial agents
12/08/2004	EP1210118B1 Composition comprising a tramadol material and an anticonvulsant drug
12/08/2004	EP1171107B1 Use of a pharmaceutical composition in the manufacture of a medicament for the treatment of pathological conditions of the eye caused by bacteria, viruses, fungi, yeasts and protozoa
12/08/2004	EP1168934A4 Hydrogel-forming system with hydrophobic and hydrophilic components
12/08/2004	EP1149102B1 Triazolo-pyridazine derivatives as ligands for gaba receptors
12/08/2004	EP1127052B1 Substituted 2-phenylbenzimidazoles, the production thereof and their use
12/08/2004	EP1121369B1 Ribavirin-interferon alfa combination therapy for eradicating detectable hcv-rna in patients having chronic hepatitis c infection
12/08/2004	EP1121354B1 N-(imidazolylalkyl)substituted cyclic amines as histamine-h 3 agonists or antagonists
12/08/2004	EP1119548B1 3-(3-chloro-4-hydroxyphenylamino)-4-(2-nitrophenyl)-1h-pyrrole-2,5-dione as glycogen synthase kinase-3 inhibitor (gsk-3)
12/08/2004	EP1114040B1 PROCESS FOR OBTAINING HMG-CoA REDUCTASE INHIBITORS OF HIGH PURITY
12/08/2004	EP1112998B1 Amine derivatives
12/08/2004	EP1035847A4 Stable solution of zinc and bicarbonate ions
12/08/2004	EP1027330B1 Styryl sulfone anticancer agents
12/08/2004	EP1027062B1 Germicidal compositions for the treatment of animal infectious diseases of the hoof, comprising a copper salt, a quaternary ammonium compound and a peroxide
12/08/2004	EP1014999B1 Cationic polymers as toxin-binding agents
12/08/2004	EP0991402B1 Process for preparing a poly(vinyl alcohol) cryogel
12/08/2004	EP0981342B1 Method and composition for treating cancers
12/08/2004	EP0975329B1 Lipid complexes of highly insoluble platinum complexes
12/08/2004	EP0952836B1 Use of sulphoquinovosyldiacylglycerols for the treatment of inflammatory skin diseases
12/08/2004	EP0920312B1 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents
12/08/2004	EP0904086B1 Transdermal systems containing two active principles in separate compartments, their method of preparation and application as medicine
12/08/2004	EP0904067B1 Transdermally administered dextromethorphan as antitussive agent
12/08/2004	EP0863729B1 Implantable controlled release device to deliver drugs directly to an internal portion of the body
12/08/2004	EP0812190B1 R-enantiomer of n-propargyl-1-aminoindan for the treatment of various diseases and mesylate, esylate and sulfate thereof
12/08/2004	EP0801570B1 Formulations and methods for reducing skin irritation
12/08/2004	CN1554026A Prognostic indicator
12/08/2004	CN1553963A Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells
12/08/2004	CN1553958A Photochemical internalization for delivery of molecules into the cytosol
12/08/2004	CN1553927A Quaternary polyamidoamines, the production thereof, corresponding agents and the use thereof
12/08/2004	CN1553918A Novel dammarane sapogenins, their use as anti-cancer agents, and a process for producing same
12/08/2004	CN1553917A 17alpha-hydroxy-14beta-steroids with hormonal effect
12/08/2004	CN1553916A Heteroaryl substituted fused bicyclic heteroaryl compounds as GABAA receptor ligands
12/08/2004	CN1553915A Method for the preparation of hexahydro-furo-[2,3-b]furan-3-ol
12/08/2004	CN1553911A Pyrrole derivatives, their preparation and their therapeutic uses
12/08/2004	CN1553910A Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands
12/08/2004	CN1553909A Benzimidazole and pyridylimidazole derivatives as ligands for GABA receptors
12/08/2004	CN1553906A VARIOLIN derivatives and their use as antitumor agents
12/08/2004	CN1553905A Novel urea compounds as vanilloid receptor antagonist for treatment of pains
12/08/2004	CN1553901A New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds
12/08/2004	CN1553900A Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents
12/08/2004	CN1553899A Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus proliferator receptor and medicinal composition containing the same
12/08/2004	CN1553895A Taxol enhancer compounds
12/08/2004	CN1553894A Taxol enhancer compounds
12/08/2004	CN1553892A Novel compounds and compositions as cathepsin inhibitors
12/08/2004	CN1553890A Crystals of hydroxynorephedrine derivative
12/08/2004	CN1553816A Polysaccharide-containing compositions and use thereof
12/08/2004	CN1553815A Pharmaceutical formulation for the intramuscular administration of fulvestrant
12/08/2004	CN1553814A Remedies for arteriosclerosis
12/08/2004	CN1553805A Nutritional compositions for controlling blood glucose level
12/08/2004	CN1553804A Combinations for the treatment of inflammatory disorders
12/08/2004	CN1553803A Use of 4-pyridylmethylphthalazines for cancer treatment
12/08/2004	CN1553802A 喜树碱衍生物 Camptothecin derivatives
12/08/2004	CN1553801A Inhalation compositions comprising tricyclic 5,6-dihydro-9H-pyrazolo (3,4-C)-1,2,4-triazolo (4,3-alpha) pyridines
12/08/2004	CN1553800A Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders
12/08/2004	CN1553799A Dosage forms having prolonged active ingredient release
12/08/2004	CN1553798A Modifying the fatty acid composition of cell membranes of organs and tissues
12/08/2004	CN1553797A Carboxylate-gated-nitroxide (CGN) compounds and compositions and methods of use thereof
12/08/2004	CN1553795A Pharmaceutical and cosmetic compositions against skin aging
12/08/2004	CN1553794A Stable skin conditioning compositions containing retinoid boosters
12/08/2004	CN1553771A Nicotine-containing oral dosage form
12/08/2004	CN1552855A Vascular endothelial growth factor 2
12/08/2004	CN1552725A Preparation of solanine sulfurate and its use in medicine
12/08/2004	CN1552724A Preparation of solanine and its use in medicine
12/08/2004	CN1552723A Liaodong oak leaf saponin and its medicinal composition
12/08/2004	CN1552720A N,O-carboxymethyl chitoligose preparation and use
12/08/2004	CN1552712A New camptothecin analogue compounds, a process for their preparation and pharmaceutical compositions containing them
12/08/2004	CN1552710A Use of aspergillus fumigatus in antiflammation immunosuppressant
12/08/2004	CN1552708A Three compounds from traditional Chinese medicine
12/08/2004	CN1552707A 4-aryl group-5H-thoifuran-2-ketone derivative, producing method and use thereof
12/08/2004	CN1552702A Medicinal use and extraction of cis-ligusticum lactone
12/08/2004	CN1552690A Benzyl ethylene quininate derivatives, their preparations and uses
12/08/2004	CN1552474A Medicine coating rack
12/08/2004	CN1552450A Ligustrazine cyclodextrin dressing material, its preparation and preparing method
12/08/2004	CN1552449A Baicalin cyclodextrin clathrate compound, preparation and preparing method thereof
12/08/2004	CN1552448A Dewatered andrographolide cyclodextrin dressing material, its preparation and preparing method
12/08/2004	CN1552438A Medicine for decreasing vagina acidity and treating vaginitis, use thereof
12/08/2004	CN1552435A Medicine for preventing tumour
12/08/2004	CN1552352A Medicine for preventing senile dementia
12/08/2004	CN1552348A Sedinafine composition and its use
12/08/2004	CN1552346A Use of polysaccharose sulfate for preparing medicine against grippal virus
12/08/2004	CN1552345A Medicine for preventing arthritis
12/08/2004	CN1552344A Alinate/alginic acid composition

1 ... 4867 4868 4869 4870 4871 4872 4873 4874 4875 4876 4877 4878 4879 4880 4881 4882 4883 4884 4885 4886 4887 ... 7860